IQVIA to Announce First-Quarter 2019 Results on May 1, 2019
April 17 2019 - 3:15PM
Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its
first-quarter 2019 financial results before the market opens on
Wednesday, May 1, 2019. The IQVIA management team will also host a
conference call and webcast at 9:00 a.m. Eastern Daylight Time on
that date. The earnings release and accompanying financial
information will be posted on the IQVIA Investor Relations website
at http://ir.iqvia.com.
Interested parties are invited to listen to the live event and
view the presentation slides via webcast on the IQVIA Investor
Relations website at http://ir.iqvia.com. The discussion also will
be available by dialing +1-800-909-4261 in the U.S. and Canada, or
+1-212-231-2926 for international callers.
A replay of the webcast will be available approximately two
hours after the conclusion of the live event on May 1. To access
the webcast recording, visit http://ir.iqvia.com.
About IQVIA
IQVIA is a leading global provider of advanced analytics,
technology solutions and contract research services to the life
sciences industry. Formed through the merger of IMS Health and
Quintiles, IQVIA applies human data science — leveraging the
analytic rigor and clarity of data science to the ever-expanding
scope of human science — to enable companies to reimagine and
develop new approaches to clinical development and
commercialization, speed innovation and accelerate improvements in
healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers
unique and actionable insights at the intersection of large-scale
analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100
countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
IQVIAFIN
Click here to subscribe to Mobile Alerts for
IQVIA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190417005581/en/
Andrew Markwick, IQVIA Investor Relations
(andrew.markwick@iqvia.com)+1.973.257.7144Tor Constantino, IQVIA
Media Relations (tor.constantino@iqvia.com)+1.484.567.6732
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jul 2023 to Jul 2024